SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001847903-23-000158
Filing Date
2023-08-24
Accepted
2023-08-23 18:00:15
Documents
14
Period of Report
2023-08-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20230822.htm   iXBRL 8-K 29435
2 EX-99.1 orx750abstact.htm EX-99.1 10182
  Complete submission text file 0001847903-23-000158.txt   226366

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20230822.xsd EX-101.SCH 2737
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20230822_def.xml EX-101.DEF 16868
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20230822_lab.xml EX-101.LAB 34074
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20230822_pre.xml EX-101.PRE 18275
8 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20230822_htm.xml XML 4495
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 231198508
SIC: 2834 Pharmaceutical Preparations